IDEXX Laboratories, Inc. (IDXX)
532.38
-6.61
(-1.23%)
USD |
NASDAQ |
Sep 03, 12:56
IDEXX Laboratories Shareholders Equity (Quarterly) : 1.613B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.613B |
| March 31, 2026 | 1.556B |
| December 31, 2025 | 1.605B |
| September 30, 2025 | 1.561B |
| June 30, 2025 | 1.459B |
| March 31, 2025 | 1.448B |
| December 31, 2024 | 1.595B |
| September 30, 2024 | 1.618B |
| June 30, 2024 | 1.580B |
| March 31, 2024 | 1.569B |
| December 31, 2023 | 1.485B |
| September 30, 2023 | 1.297B |
| June 30, 2023 | 1.094B |
| March 31, 2023 | 841.10M |
| December 31, 2022 | 608.74M |
| September 30, 2022 | 476.00M |
| June 30, 2022 | 457.01M |
| March 31, 2022 | 639.80M |
| December 31, 2021 | 689.99M |
| September 30, 2021 | 754.75M |
| June 30, 2021 | 747.46M |
| March 31, 2021 | 702.70M |
| December 31, 2020 | 632.09M |
| September 30, 2020 | 440.58M |
| June 30, 2020 | 272.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 107.67M |
| December 31, 2019 | 177.47M |
| September 30, 2019 | 202.42M |
| June 30, 2019 | 171.25M |
| March 31, 2019 | 51.56M |
| December 31, 2018 | -9.513M |
| September 30, 2018 | -1.604M |
| June 30, 2018 | -41.13M |
| March 31, 2018 | -49.27M |
| December 31, 2017 | -54.11M |
| September 30, 2017 | -48.62M |
| June 30, 2017 | -86.34M |
| March 31, 2017 | -74.09M |
| December 31, 2016 | -108.35M |
| September 30, 2016 | 54.85M |
| June 30, 2016 | -8.638M |
| March 31, 2016 | -73.92M |
| December 31, 2015 | -84.12M |
| September 30, 2015 | -38.89M |
| June 30, 2015 | 8.468M |
| March 31, 2015 | 34.02M |
| December 31, 2014 | 117.52M |
| September 30, 2014 | 229.39M |
| June 30, 2014 | 452.87M |
| March 31, 2014 | 512.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DexCom, Inc. | 2.621B |
| Intuitive Surgical, Inc. | 18.17B |
| Abbott Laboratories | 51.11B |
| Align Technology, Inc. | 4.232B |
| Integra LifeSciences Holdings Corp. | 1.043B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.442B |
| Total Liabilities (Quarterly) | 1.830B |
| Debt to Equity Ratio | 0.6797 |
| Current Ratio | 1.110 |
| Net Debt Paydown Yield | -0.02% |